SCHEMBL9880215

SCHEMBL9880215

CCC1OC(C)C(OC(=O)c2ccccc2)C(C)C1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS9 O00182 1/20 0.45
LGALS1 P09382 1/20 0.45
LGALS3 P17931 1/20 0.45
LGALS7; LGALS7B P47929 1/20 0.45
LMNA P02545 2/20 0.40
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
TSHR P16473 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
PTPN1 P18031 3/20 0.37
GAA P10253 1/20 0.37
BCHE P06276 3/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
CHRNA7 P36544 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18874981 0.96 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA
SCHEMBL12747029 0.96 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA
SCHEMBL12150955 0.96 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA
SCHEMBL17320700 0.96 LGALS9 (0.46) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA
SCHEMBL9880223 0.89 LGALS3 (0.38) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL9880217 0.89 LGALS3 (0.38) LGALS9LGALS1LGALS3LGALS7; LGALS7BMEN1
SCHEMBL19726119 0.89 LGALS3 (0.54) LGALS9LGALS1LGALS3LGALS7; LGALS7BAPOBEC3A
SCHEMBL9880216 0.89 LGALS3 (0.54) LGALS9LGALS1LGALS3LGALS7; LGALS7BAPOBEC3A
SCHEMBL13765953 0.88 LGALS9 (0.43) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA
SCHEMBL17773533 0.88 LGALS9 (0.44) LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883170-B2 Adjuvant WESTERN ILLINOIS UNIVERSITY RESEARCH FOUNDATION (US) 2014-11-11 US disclosed
US-20120136142-A1 Vaccine Compositions For Marburg Virus SOUTHERN RESEARCH INSTITUTE (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136142-A1 Vaccine Compositions For Marburg Virus OSBPL3, OSBP2, CD81 LGALS9 281/4885LGALS1 158/4885LGALS3 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.